References
- Ciurana C. L., Hack C. E.. Competitive binding of pentraxins and IgM to newly exposed epitopes on late apoptotic cells. Cell Immunol.. 2006; 239:14–21.
- Vogt B., Fuhrnrohr B., Muller R., Sheriff A.. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity. 2007; 40:295–298.
- Kolstoe S. E., Ridha B. H., Bellotti V., . Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component. Proc. Natl. Acad. Sci. USA. 2009; 106:7619–7623.
- Garlanda C., Bottazzi B., Bastone A., Mantovani A.. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol.. 2005; 23:337–366.
- Bottazzi B., Garlanda C., Salvatori G., . Pentraxins as a key component of innate immunity. Curr. Opin. Immunol.. 2006; 18:10–15.
- Agrawal A., Singh P. P., Bottazzi B., Garlanda C., Mantovani A.. Pattern recognition by pentraxins. Adv. Exp. Med. Biol.. 2009; 653:98–116.
- Janko C., Franz S., Munoz L. E., . CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immunol.. 2011; 2:70.
- Du Clos T. W., Mold C.. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcgamma receptors. Curr. Opin. Organ Transplant.. 2011; 16:15–20.
- Das T., Mandal C.. Protein A–a new ligand for human C-reactive protein. FEBS Lett.. 2004; 576:107–113.
- Serban D., Rordorf-Adam C.. Binding characteristics of human serum amyloid P component. Scand. J. Immunol.. 1987; 25:275–281.
- Slagman A. C., Bock C., Abdel-Aty H., . Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model. Blood Purif.. 2011; 31:9–17.